Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Amdocs (DOX) over the last 17 years, with Q4 2025 value amounting to $32.2 million.

  • Amdocs' Gains from Investment Securities fell 3499.1% to $32.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $105.1 million, marking a year-over-year decrease of 4344.66%. This contributed to the annual value of $901000.0 for FY2025, which is 2226.06% down from last year.
  • Per Amdocs' latest filing, its Gains from Investment Securities stood at $32.2 million for Q4 2025, which was down 3499.1% from $13.2 million recorded in Q3 2025.
  • In the past 5 years, Amdocs' Gains from Investment Securities registered a high of $65.0 million during Q2 2023, and its lowest value of $13.2 million during Q3 2025.
  • Its 5-year average for Gains from Investment Securities is $35.2 million, with a median of $33.9 million in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 42971.07% in 2021, then tumbled by 5969.57% in 2025.
  • Over the past 5 years, Amdocs' Gains from Investment Securities (Quarter) stood at $16.3 million in 2021, then skyrocketed by 159.33% to $42.4 million in 2022, then rose by 20.98% to $51.3 million in 2023, then fell by 3.33% to $49.5 million in 2024, then tumbled by 34.99% to $32.2 million in 2025.
  • Its last three reported values are $32.2 million in Q4 2025, $13.2 million for Q3 2025, and $30.2 million during Q2 2025.